BiBBInstruments developed the CE-marked electromechanical biopsy instruments for endoscopic use, which aims to improve the current diagnosis of serious and difficult-to-diagnose tumours. The directed share issue, conducted earlier this year, creates opportunities for the company to continue its development and present several clinical news in the coming year.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 SEK | -1.54% | +10.34% | +102.53% |
20/05 | Sweden's BiBBInstruments to Issue SEK10 Million Shares | MT |
17/05 | BiBBInstruments Expands Clinical Evaluation of Endoscopy Instrument in Scandinavia | MT |
1st Jan change | Capi. | |
---|---|---|
+102.53% | 17.73M | |
-26.77% | 16.48B | |
-43.46% | 2.79B | |
+22.46% | 1.94B | |
-12.32% | 1.46B | |
+31.49% | 1.33B | |
-16.15% | 966M | |
+1.33% | 791M | |
-31.07% | 788M | |
-25.95% | 620M |
- Stock Market
- Equities
- BIBB Stock
- News BiBBInstruments AB
- BiBBInstruments Develops the CE-Marked Electromechanical Biopsy Instruments for Endoscopic Use